Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of$0.05. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 80%. A quarter ago, it was expected that this company would post earnings of $0.03 per share when it actually produced earnings of$0.07, delivering a surprise of 133.33%.Over the last four quarters, the comp ...